Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm

NCT01691313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Atrial Fibrillation
Atrial Flutter

Interventions

DRUG: Vanoxerine
DRUG: Placebo

Sponsor

Laguna Pharmaceuticals, Inc.